Skip to main content Accessibility help
×
Home

Contents:

Information:

  • Access

Figures:

Actions:

      • Send article to Kindle

        To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

        Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

        Find out more about the Kindle Personal Document Service.

        Targeted delivery of propionate to the human colon prevents body weight and intra-abdominal adipose tissue gain in overweight adults
        Available formats
        ×

        Send article to Dropbox

        To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

        Targeted delivery of propionate to the human colon prevents body weight and intra-abdominal adipose tissue gain in overweight adults
        Available formats
        ×

        Send article to Google Drive

        To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

        Targeted delivery of propionate to the human colon prevents body weight and intra-abdominal adipose tissue gain in overweight adults
        Available formats
        ×
Export citation

The colonic microbiota ferment available carbohydrates, producing short chain fatty acids (SCFAs), which trigger the release of the anorectic gut hormones peptide YY (PYY) and glucagon like peptide-1 (GLP-1) by stimulating the free fatty acid receptors (FFAR) 2 and 3 on the enteroendocrine L cells( 1 ). We have developed a novel inulin propionate ester that targets delivery of gram quantities of the SCFA propionate to the human colon and which significantly increases PYY and GLP-1 secretion and reduces food intake following acute ingestion at a dose of 10 g (unpublished observation). We hypothesised that long-term supplementation with propionate ester would prevent weight gain in overweight adults.

Forty nine men and women aged 40–65 years, with a body mass index (BMI) of 25–40 kg/m2 were recruited and randomly assigned to receive either 10 g/day inulin control (n = 24) or 10 g/day propionate ester (n = 25) for 24-weeks. Body composition data, assessed using magnetic resonance imaging, was collected from 17 subjects in the propionate ester group and 15 subjects in the control group.

AT, adipose tissue. **P < 0.01 within-group, ***P < 0.001 within-group, †P < 0.05 between groups.

Significantly fewer subjects gained ⩾3% (P = 0.036) and >5% (P = 0.033) of their baseline body weight following propionate ester supplementation. Weight loss after 24 weeks was greater in the propionate ester group, but this effect was not significantly different between groups (−1.02 kg [95% CI, −2.10 to 0.04] propionate ester vs. 0.38 kg [95% CI, −0.95 to 1.72] control; P = 0.099). The change in the distribution of intra-abdominal adipose tissue (AT) was significantly lower in the propionate ester group compared with control supplementation (P = 0.027). Furthermore, internal AT (P = 0.002) was significantly increased within the control group, but not in the propionate ester group.

In conclusion, this investigation provides the first direct evidence that colonic propionate can prevent body weight and intra-abdominal AT gain in humans. Dietary strategies that promote colonic propionate production may play a role in weight management over the life-course.

This work was supported by the Biotechnology & Biological Sciences Research Council (BB/H004971/1). The clinical trial (NCT00750438) was conducted in accordance with the Declaration of Helsinki.

1. Tolhurst, G, Heffron, H, Lam, YS, et al. (2011) Diabetes 61, 364371.